Editas Medicine GAAP EPS of -$0.76 misses by $0.18, revenue of $1.14M misses by $6.16M [Seeking Alpha]
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Royal Bank of Canada from $417.00 to $424.00. They now have a "sector perform" rating on the stock.
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Piper Sandler from $450.00 to $456.00. They now have an "overweight" rating on the stock.
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.